Therapeutically focused CRO INC Research has promoted Garth Tierney to executive vice president, Asia/Pacific, responsible for driving the strategic development and overall growth of Asia/Pacific clinical research operations. Tierney, who was INC Research’s regional general manager for Australia and Southeast Asia, co-founded Trident Clinical Research, an Australia-based CRO acquired by INC Research in 2011 after 14 years of operation.
"INC Research is experiencing tremendous opportunity to help drug developers navigate the diverse and complex landscape of conducting trials across the Asia/Pacific region, especially as many countries are poised to significantly increase their investment in clinical research," said Tierney.
Previously, Tierney worked for eight years in the clinical research industry in various senior management and operational management roles across several companies, including a global CRO, an Australian pharmaceutical company and two global pharmaceutical companies.
Tierney succeeds Kelvin Logan, Ph.D., who will retire in April. Dr. Logan joined INC Research in 2002 as its first employee outside North America and played an instrumental role in growing the EMEA and Asia/Pacific regions to 2,200 staff and 43 offices.